Novartis India Limited (NSE:NOVARTIND)
1,388.90
+24.60 (1.80%)
Jun 19, 2026, 3:29 PM IST
Novartis India Market Cap
Novartis India has a market cap or net worth of 34.28 billion as of June 18, 2026. Its market cap has increased by 33.29% in one year.
Market Cap
34.28B
Enterprise Value
27.64B
Revenue
3.54B
Ranking
n/a
PE Ratio
36.79
Stock Price
1,388.90
Market Cap Chart
Since April 14, 1999, Novartis India's market cap has increased from 12.59B to 34.28B, an increase of 172.40%. That is a compound annual growth rate of 3.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 34.28B | 78.23% |
| Dec 31, 2025 | 19.23B | -15.31% |
| Dec 31, 2024 | 22.71B | 18.95% |
| Dec 29, 2023 | 19.09B | 14.56% |
| Dec 30, 2022 | 16.67B | -12.94% |
| Dec 31, 2021 | 19.14B | 13.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharma Advanced Research Company | 78.69B |
| Aarti Pharmalabs | 59.70B |
| Innova Captab | 53.39B |
| Orchid Pharma | 51.14B |
| RPG Life Sciences | 37.67B |
| Solara Active Pharma Sciences | 27.34B |
| Indoco Remedies | 21.42B |
| Beta Drugs | 20.09B |